«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:

期数:

2023年03期

页码:

435-437

栏目:

综述

出版日期:

2023-06-20

文章信息/Info

Title:

-

作者:

郝昭昭¹; 2; 李 多¹; 南岩东¹

710038 西安,空军军医大学唐都医院呼吸与危重症医学科¹
710021 西安,西安医学院²

Author(s):

-

关键词:

磨玻璃结节;  肿瘤微环境;  肺腺癌;  发生机制

Keywords:

-

分类号:

R563

DOI:

10.3877/cma.j.issn.1674-6902.2023.03.039

摘要:

-

Abstract:

-

参考文献/References:

1 刘宝东. 肺磨玻璃结节的诊治策略[J]. 中国肺癌杂志, 2019,22(07): 449?456.
2 Kudo Y, Matsubayashi J, Saji H, et al. Association between high?resolution computed tomography findings and the IASLC/ ATS/ ERS classification of small lung adenocarcinomas in Japanese patients[J].Lung Cancer, 2015, 90(1): 47?54.
3 Yang J, Wang H, Geng C, et al. Advances in intelligent diagnosis methods for pulmonary ground?glass opacity nodules[J]. Biomed Eng Online, 2018, 17(1): 20.
4 Yang YQ, Lu Z, Gao J, et al. Correlations between vessel changes and the histopathologic subtypes of lung adenocarcinoma with pure ground?glass nodule on computed tomography[J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2016, 38(2): 182?186.
5 Wu XL, Xu QZ, Chen T, et al. Establishment and analysis of prediction model for invasive subsolid pulmonary nodules based on radiomics[J]. Zhonghua Yi Xue Za Zhi, 2022, 102(3): 209?215.
6 Liu Y, Sun H, Zhou F, et al. Imaging features of TSCT predict the classification of pulmonary preinvasive lesion, minimally and invasive adenocarcinoma presented as ground glass nodules[J]. Lung Cancer,2017, 108: 192?197.
7 Qi L, Lu W, Yang L, et al. Qualitative and quantitative imaging features of pulmonary subsolid nodules: differentiating invasive adenocarcinoma from minimally invasive adenocarcinoma and preinvasive lesions[J]. J Thorac Dis, 2019, 11(11): 4835?4846.
8 Lee HW, Jin K N, Lee JK, et al. Long?term follow?up of ground?glass nodules after 5 years of stability[J]. J Thorac Oncol, 2019, 14(8): 1370?1377.
9 Shen L, Lin J, Wang B, et al. Computed tomography findings, clinicopathological features, genetic characteristics and prognosis of in situ and minimally invasive lung adenocarcinomas[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2019, 39(9): 1107?1112.
10 Wang T, Zhang T, Han X, et al. Impact of the international association for the study of lung cancer/ American thoracic society/European respiratory society classification of stage IA adenocarcinoma of the lung: Correlation between computed tomography images and EGFR and KRAS gene mutations[J]. Exp Ther Med, 2015, 9(6): 2095?2103.
11 Nie M, Yao K, Zhu X, et al. Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma [ J ]. Nature Communications, 2021, 12(1): 6479.
12 Xiang W, Xing Y, Jiang S, et al. Morphological factors differentiating between early lung adenocarcinomas appearing as pure ground?glass nodules measuring 13 Kitami A, Sano F, Hayashi S, et al. Correlation between histological invasiveness and the computed tomography value in pure ground?glass nodules[J]. Surg Today, 2016, 46(5): 593?598.
14 Marx A, Chan JK, Coindre JM, et al. The 2015 World Health Organization Classification of tumors of the thymus: Continuity and changes[J]. J Thorac Oncol, 2015, 10(10): 1383?1395.
15 沈 丹, 江德鹏, 蒋幼凡. 未吸烟人群慢性阻塞性肺疾病与肺癌危险关系的系统评价[J]. 重庆医科大学学报, 2016, 41(4):360?363.
16 Selamat SA, Galler JS, Joshi AD, et al. DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma[J]. PLoS One, 2011, 6(6): e21443.
17 Kerr KM, Galler JS, Hagen JA, et al. The role of DNA methylation in the development and progression of lung adenocarcinoma[J]. Dis Markers, 2007, 23(1?2): 5?30.
18 Selamat SA, Galler JS, Joshi AD, et al. DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma[J]. PLoS One, 2011, 6(6): e21443.
19 Lahn M, Su C, Li S, et al. Expression levels of protein kinase C?alpha in non?small?cell lung cancer[J]. Clin Lung Cancer, 2004, 6 (3): 184?189.
20 Yamada G, Murata M, Takasawa A, et al. Increased expressions of claudin 4 and 7 in atypical adenomatous hyperplasia and adenocarcinoma of the lung[J]. Med Mol Morphol, 2016, 49(3): 163?169.
21 Ilie M, Long E, Hofman V, et al. Diagnostic value of immunohistochemistry for the detection of the BRAF mutation in primary lung adenocarcinoma Caucasian patients[J]. Ann Oncol, 2013, 24(3): 742?748.
22 Zhou QJ, Zheng ZC, Zhu YQ, et al. Tumor invasiveness defined by IASLC/ ATS/ ERS classification of ground?glass nodules can be predicted by quantitative CT parameters[J]. J Thorac Dis, 2017, 9(5): 1190?1200.
23 Sun K, Xie H, Zhao J, et al. A clinicopathological study of lung adenocarcinomas with pure ground?glass opacity > 3 cm on high?resolution computed tomography[ J]. Eur Radiol, 2022, 32(1): 174?183.
24 Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification[J]. J Thorac Oncol, 2015, 10(9): 1243?1260.
25 Belinsky SA, Snow SS, Nikula K J, et al. Aberrant CpG island methylation of the p16(INK4a) and estrogen receptor genes in rat lung tumors induced by particulate carcinogens[J]. Carcinogenesis, 2002, 23(2): 335?339.
26 Xu X, Li N, Zhao R, et al. Targeted next?generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ[J]. J Cancer Res Clin Oncol, 2017, 143(12): 2447?2453.
27 Kimura K, Matsumoto S, Harada T, et al. ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target[J]. Cancer Sci, 2020, 111(3): 951?961.
28 Shin DH, Kim SH, Choi M, et al. Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2?NRG1 fusion via ADAM17?mediated shedding of NRG1[J]. Oncogene, 2022, 41(2): 280?292.
29 Kim EY, Cha YJ, Lee SH, et al. Early lung carcinogenesis and tumor microenvironment observed by single?cell transcriptome analysis[J]. Transl Oncol, 2022, 15(1): 101277.
30 Lu T, Yang X, Shi Y, et al. Single?cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodules [J]. Cell Discovery, 2020, 6: 69.
31 Braile M, Marcella S, Cristinziano L, et al. VEGF?A in cardiomyocytes and heart diseases[J]. Int J Mol Sci, 2020, 21(15): 5294.
32 Bergers G, Hanahan D. Modes of resistance to anti?angiogenic therapy[J]. Nat Rev Cancer, 2008, 8(8): 592?603.
33 Liu Y, Sun H, Zhou F, et al. Imaging features of TSCT predict the classification of pulmonary preinvasive lesion, minimally and invasive adenocarcinoma presented as ground glass nodules[J]. Lung Cancer,2017, 108:192?197.
34 Li G, Wu F, Yang H, et al. MiR?9?5p promotes cell growth and metastasis in non?small cell lung cancer through the repression of TGFBR2[J]. Biomed Pharmacother, 2017, 96: 1170?1178.
35 Naito M, Aokage K, Saruwatari K, et al. Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung[J]. Lung Cancer, 2016, 100: 53?62.
36 Koshikawa N, Giannelli G, Cirulli V, et al. Role of cell surface metalloprotease MT1?MMP in epithelial cell migration over laminin?5 [J]. J Cell Biol, 2000, 148(3): 615?624.
37 Song X, Chen Q, Wang J, et al. Clinical and prognostic implications of an immune?related risk model based on TP53 status in lung adenocarcinoma[J]. J Cell Mol Med, 2022, 26(2): 436?448.
38 Yim J, Zhu L C, Chiriboga L, et al. Histologic features are important prognostic indicators in early stages lung adenocarcinomas[J]. Mod Pathol, 2007, 20(2): 233?241.
39 Sholl LM, Yeap BY, Iafrate AJ, et al. Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never?smokers[J]. Cancer Res, 2009, 69(21): 8341? 8348.
40 Soh J, Toyooka S, Ichihara S, et al. Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung[J]. J Thorac Oncol, 2008, 3(4): 340?347.
41 Yatabe Y, Takahashi T, Mitsudomi T. Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR?mutated lung cancer[J]. Cancer Res, 2008, 68(7): 2106?2111.
42 戴书华, 刘国芳, 向东生. 肺磨玻璃结节CT 值测量在早期癌症诊断中的意义[J/ CD]. 中华肺部疾病杂志(电子版), 2019, 12(6): 770?771.

备注/Memo

备注/Memo:

基金项目: 陕西省重点研发计划(2019SF-009)
唐都医院创新发展基金(2017LCYJ016)
通信作者: 南岩东, Email: nanyandong2008@163.com

常用功能

更新日期/Last Update: 2023-06-20